Laura Brege, Director: Acadia Pharmaceuticals ACAD Sell · Filed 25/06/05

Trade details

Type: Insider sale
Amount: $314,633.88
Shares · price: 14,446 sh · $21.78 a share
Held after: 15,095 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Laura BregeDirector
Trade date: 25/06/04
Filed: 25/06/05
Days to filing: 1 days

Sold 48.9% of holdings

Share of holding sold: 48.9%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/05/05~25/07/04

Laura Brege's recent trades

Laura BregeDirector
SellMirum Pharmaceuticals
Sell
Mirum Pharmaceuticals
MIRM
$1.2M
15,509 sh
$1.2M
Filed 25/09/12
Traded 25/09/11
Laura BregeDirector
SellMirum Pharmaceuticals
Sell
Mirum Pharmaceuticals
MIRM
$111.9K
1,491 sh
$111.9K
Filed 25/09/12
Traded 25/09/11
Laura BregeDirector
Planned saleMirum Pharmaceuticals
Planned sale
Mirum Pharmaceuticals
MIRM
$1.3M
17,000 sh
$1.3M
Filed 25/09/11
Traded 25/09/11
Laura BregeDirector
Planned saleAcadia Pharmaceuticals
Planned sale
Acadia Pharmaceuticals
ACAD
$314.6K
14,446 sh
$314.6K
Filed 25/06/04
Traded 25/06/04
Laura BregeDirector
BuyPacira BioSciences
Buy
Pacira BioSciences
PCRX
$12.8K
1,000 sh
$12.8K
Filed 24/08/19
Traded 24/08/16